Cellebrite DI Ltd.

NASDAQ:CLBT

18.49 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 95.71489.58293.01384.17976.68471.23474.01871.67562.57362.38567.90865.88759.16853.28357.16853.24145.7738.734
Cost of Revenue 16.26113.26414.91612.87813.03112.40612.13114.53413.09810.98312.33611.95410.0688.19910.529.5018.2199.639
Gross Profit 79.45376.31878.09771.30163.65358.82861.88757.14149.47551.40255.57253.93349.145.08446.64843.7437.55129.095
Gross Profit Ratio 0.830.8520.840.8470.830.8260.8360.7970.7910.8240.8180.8190.830.8460.8160.8220.820.751
Reseach & Development Expenses 23.69323.19721.75120.45121.05321.13119.73421.63519.67519.57618.83316.42715.38814.89314.77112.89913.70213.005
General & Administrative Expenses 10.95311.81511.75310.49811.2329.968.8111.02410.50710.51311.19420.4756.9829.2866.7736.6969.147.252
Selling & Marketing Expenses 32.3232.05929.59426.87326.74527.60123.66925.56724.89223.25921.23920.12318.50916.51817.76315.16213.04415.336
SG&A 43.27343.86541.34737.37137.97737.56132.47936.59135.39933.77232.43340.59825.49125.80424.53621.85822.18422.588
Other Expenses 00000000002.6310-0.05-0.0492.273000
Operating Expenses 66.96667.06263.09857.82259.0358.69252.21358.22655.07453.34851.26657.02540.87940.69741.5834.75735.88635.593
Operating Income 12.4879.25614.99913.4794.6230.1369.674-1.085-5.599-1.9464.306-3.0928.2214.3875.0688.9831.665-6.498
Operating Income Ratio 0.130.1030.1610.160.060.0020.131-0.015-0.089-0.0310.063-0.0470.1390.0820.0890.1690.036-0.168
Total Other Income Expenses Net -34.502-78.585-27.344-6.63-36.051-38.775-0.57225.42238.46656.4-50.00317.8120.4960.3660.6050.4171.0150.142
Income Before Tax -22.015-69.329-12.3456.849-31.428-38.6399.10224.33732.86754.45454.11514.728.7174.7535.6739.42.68-6.356
Income Before Tax Ratio -0.23-0.774-0.1330.081-0.41-0.5420.1230.340.5250.8730.7970.2230.1470.0890.0990.1770.059-0.164
Income Tax Expense 1.7962.0432.3020.3490.921.9662.024-0.755-0.33-0.9842.2446.5810.9211.1632.7191.2790.7170.901
Net Income -23.811-71.372-14.6476.5-32.348-40.6057.07825.09233.19755.43851.8718.1397.7963.592.9548.1211.963-11.038
Net Income Ratio -0.249-0.797-0.1570.077-0.422-0.570.0960.350.5310.8890.7640.1240.1320.0670.0520.1530.043-0.285
EPS -0.12-0.36-0.0750.034-0.17-0.220.0380.130.170.280.280.060.0440.0190.0160.0430.011-0.086
EPS Diluted -0.12-0.36-0.0750.032-0.17-0.220.0370.130.170.280.250.050.0420.0190.0160.0430.011-0.086
EBITDA 15.06311.93617.61415.8597.1922.58312.1941.22-3.3420.1666.12-0.9959.9195.8696.60110.6723.171-5.347
EBITDA Ratio 0.1570.1330.1890.1880.0940.0360.1650.017-0.0530.0030.09-0.0150.1680.110.1150.20.069-0.138